Lars S. Maier

1998–2025 年に発表

173
論文数
21,151
被引用数
82
h 指数
161
i10 指数

被引用数

Lars S. Maier の年別被引用数1991 年: 被引用 1 件1999 年: 被引用 3 件2000 年: 被引用 24 件2001 年: 被引用 15 件2002 年: 被引用 30 件2003 年: 被引用 56 件2004 年: 被引用 75 件2005 年: 被引用 57 件2006 年: 被引用 106 件2007 年: 被引用 113 件2008 年: 被引用 124 件2009 年: 被引用 176 件2010 年: 被引用 199 件2011 年: 被引用 202 件2012 年: 被引用 172 件2013 年: 被引用 201 件2014 年: 被引用 244 件2015 年: 被引用 186 件2016 年: 被引用 139 件2017 年: 被引用 140 件2018 年: 被引用 173 件2019 年: 被引用 559 件2020 年: 被引用 804 件2021 年: 被引用 760 件2022 年: 被引用 614 件2023 年: 被引用 485 件2024 年: 被引用 780 件2025 年: 被引用 399 件2026 年: 被引用 10 件1992〜1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,995 件、この内訳の 22.6%ドイツ: 引用元論文 999 件、この内訳の 11.3%中国: 引用元論文 724 件、この内訳の 8.2%イギリス: 引用元論文 615 件、この内訳の 7%イタリア: 引用元論文 515 件、この内訳の 5.8%オランダ: 引用元論文 361 件、この内訳の 4.1%カナダ: 引用元論文 341 件、この内訳の 3.9%フランス: 引用元論文 288 件、この内訳の 3.3%日本: 引用元論文 208 件、この内訳の 2.4%スペイン: 引用元論文 190 件、この内訳の 2.1%スイス: 引用元論文 165 件、この内訳の 1.9%オーストラリア: 引用元論文 151 件、この内訳の 1.7%
0%22.6%その他 25.7%

分野

  • Medicine65.8%
  • Biochemistry, Genetics and Molecular Biology23.1%
  • Engineering6.6%
  • Neuroscience2.2%
  • Immunology and Microbiology0.6%
  • Computer Science0.3%
  • その他1.4%

トピック

  • Cardiac electrophysiology and arrhythmias8%
  • Cardiovascular Function and Risk Factors4.6%
  • Ion channel regulation and function4.6%
  • Cardiomyopathy and Myosin Studies3.3%
  • Pluripotent Stem Cells Research2.8%
  • Mechanical Circulatory Support Devices2.7%
  • その他74%

共著者

全論文

検索で開く
  1. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 1,172

  2. Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation

    著者: , , , , , , , , , , , , , , , , , , , , , - Cardiovascular Research 2020 被引用: 316

  3. Transcatheter or Surgical Treatment of Aortic-Valve Stenosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Çhristof Schmid, Hölger Thiele, Raphael Twerenbold, Thomas Walther, Dirk Westermann, Erion Xhepa, Andreas Ziegler, Volkmar Falk - New England Journal of Medicine 2024 被引用: 226

  4. DFV890: a new oral NLRP3 inhibitor—tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ederlon Rezende, Caio Vinicius Gouvêa Jaoude, Ellen Pierre de Olivera, Vania Quinato Malacize, Claudio Stadnik, Eduarda Annoni Ramos, Graziela Regina Kist, Gynara Rezende Barbosa, Henrique Filik, Sabrina Nalin, Charlotte Suppli Ulrik, Casper Tidemandsen, Kjell Erik Julius Håkansson, Thomas Benfield, Karen Brorup Pedersen, Tobias Welte, Marcus Bachman, Mathias Stoll, Ilona Olzik, Natascha Scharf, Nicole Shearman, Isabell Pink, Anna Frey, Petra Schulze, Cyrus Sayehli, Dirk Weismann, Hartwig Klinker, Maria-Elisabeth Goebeler, Lars S. Maier, Florian Geismann, Frank Hanses, Judith Zeller, Julian Hupf, Matthias Lubnow, Sabine Sag, Sarah Ripfel, Steffen Pabel, Stilla Bauernfeind, Ulf Leisner, Florian Hitzenbichler, Ildikó Madurka, Dora Iharos, Krisztina Kormosoi Toth, Maria Hejja, Tamas Esze, Sushma Bhatnagar, Anant Mohan, Anuja Pandit, Balbir Kumar, Brajesh Kumar Ratre, Pawan Tiwari, Ram Singh, Saurabh Vig, Shweta Bhopale, S. Bhan, Akshay Budhraja, Ankit Agrawal, Srikanth V. Krishnamurthy, Ambika Srikanth, Kalaiyamishan Kaneesan, Mauila Raghavan Jaymohan Unnithan, Nagarajan Srinivasan, Nandagopal Velayuthaswamy, Senthil Kumar Mothu Gounder, Venkatraman Vaidyanathan, Amitabha Saha, Abhishek Bhattacharjee, Avijatri Datta, Adrián Rendón, Adrián Camacho Ortiz ほか 71 名 - Infection 2022 被引用: 83

  5. One-Year Outcomes after PCI Strategies in Cardiogenic Shock

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steffen Schneider, Uwe Zeymer, Steffen Desch - New England Journal of Medicine 2018 被引用: 431

  6. Empagliflozin Reduces Ca/Calmodulin-Dependent Kinase II Activity in Isolated Ventricular Cardiomyocytes

    著者: , , , , , , , , , , , , , , , , , , , - ESC Heart Failure 2018 被引用: 236

  7. Oxidized Ca 2+ /Calmodulin-Dependent Protein Kinase II Triggers Atrial Fibrillation

    著者: , , , , , , , , , , , , , , , , , , , , , - Circulation 2013 被引用: 313

  8. Empagliflozin Directly Improves Diastolic Function in Human Heart Failure

    著者: , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2018 被引用: 220

  9. Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michał Kowara, Bartosz Rymuza, Mariusz Kłopotowski, Łukasz A. Małek, Dániel Aradi, Gábor Veress, András Döme Dézsi, Béla Merkely, Árpád Lux, Róbert Gábor Kiss, Judit Papp, Andrea Kovács, Csaba András Dézsi, Sayour Amer, Zoltán Ruzsa, Szilárd Róna, András Komócsi, Renáta Ili, Imre Ungi, Ferenc Nagy, Robert Zweiker, Gábor Tóth-Gayor, Kurt Huber, Paul M. Haller, Wolfgang von Scheidt, A. Blüthgen, Franz‐Josef Neumann, Dietmar Trenk, Stefan Leggewie, Hans Ulrich Kreider-Stempfle, T. Remp, Kaffer Kara, Andreas Mügge, Alexander Wutzler, Stephan Fichtlscherer, Andreas M. Zeiher, Florian Seeger, Martin Hinterseer, Andreas König, Susanne Lederle, Claudius Jacobshagen, Frauke Czepluch, Lars S. Maier, Wolfgang Schillinger, Samuel Sossalla, Astrid Hummel, Stephan B. Felix, Mahir Karakas, Karsten Sydow, Tanja K. Rudolph, Marcel Halbach, Tommaso Gori, Thomas Münzel, Andreas E. May, Carsten-Manuel Gerstenberg, Dávid Pilecky, Johannes Rieber, Markus Deichstetter, Dirk Sibbing, Julinda Mehilli, Lisa Groß, Stefan Kääb, Anja Löw, Martin Orban, Matthias Orban, Stefan M. Sattler, Sabine Deuschl, Daniel Teupser, Lesca M. Holdt, Harald Mudra ほか 14 名 - The Lancet 2017 被引用: 590

  10. Assessment of Artificial Intelligence in Echocardiography Diagnostics in Differentiating Takotsubo Syndrome From Myocardial Infarction

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeroen J. Bax, Frank Ruschitzka, Jelena-Rima Ghadri, Joachim M. Buhmann, Christian Templin - JAMA Cardiology 2022 被引用: 74

  11. Empagliflozin Inhibits Na+/H+ Exchanger Activity in Human Atrial Cardiomyocytes

    著者: , , , , , , , , - ESC Heart Failure 2020 被引用: 112

  12. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial

    著者: , , , , , , , , , , , , , , , , - European Heart Journal 2018 被引用: 366

  13. Effects of Atrial Fibrillation on the Human Ventricle

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Circulation Research 2022 被引用: 82

  14. Empagliflozin Inhibits Cardiac Late Sodium Current by Ca/Calmodulin-Dependent Kinase II

    著者: , , , , , , , , , , , - Circulation 2022 被引用: 50

  15. A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marc Freichel, Hermann‐Josef Gröne, Patrick Most, Oliver J. Müller, Stephan Herzig, Eileen E. M. Furlong, Hugo A. Katus, Johannes Backs - Nature Medicine 2017 被引用: 137

  16. The δ isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload

    著者: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 被引用: 433

  17. CaMKII-Dependent Diastolic SR Ca 2+ Leak and Elevated Diastolic Ca 2+ Levels in Right Atrial Myocardium of Patients With Atrial Fibrillation

    著者: , , , , , , , , , - Circulation Research 2010 被引用: 408

  18. Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels

    著者: , , , , , , , , , , , - Journal of Clinical Investigation 2006 被引用: 554

  19. Therapy duration and improvement of ventricular function in de novo heart failure: the Heart Failure Optimization study

    著者: , , , , , , , , , , , - European Heart Journal 2024 被引用: 58

  20. The δ C Isoform of CaMKII Is Activated in Cardiac Hypertrophy and Induces Dilated Cardiomyopathy and Heart Failure

    著者: , , , , , , - Circulation Research 2003 被引用: 561

  21. Cardiac fibroblasts support cardiac inflammation in heart failure

    著者: , , , , , , , , , , , - Basic Research in Cardiology 2014 被引用: 162

  22. Oxidized CaMKII and O-GlcNAcylation cause increased atrial fibrillation in diabetic mice by distinct mechanisms

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 被引用: 78

  23. Rationale and Design of the DIGIT-HF Trial (DIGitoxin to Improve Outcomes in Patients with Advanced Chronic Heart Failure): A Randomized, Double-Blind, Placebo-Controlled Study

    著者: , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2019 被引用: 83

  24. Epigenetic balance of aberrant Rasal1 promoter methylation and hydroxymethylation regulates cardiac fibrosis

    著者: , , , , , , , , , , - Cardiovascular Research 2015 被引用: 148